Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

GLOBAL MARKETS-Asian shares fall as fresh outbreaks overshadow vaccine progress

Published 2020-11-18, 07:08 p/m
© Reuters.

By Chibuike Oguh

NEW YORK, Nov 18 (Reuters) - Asian stocks followed Wall Street's sharp selloff on Thursday as concerns about rising coronavirus infections and new shutdowns in major U.S. cities hosed down earlier investor enthusiasm about COVID-19 vaccine developments.

Bearish sentiment triggered a late-session retreat in stock markets on Wednesday after a surge in new COVID-19 infections prompted New York City, which has the largest school district in the United States, to halt in-person learning starting from Thursday.

The news of the shutdowns overshadowed Pfizer Inc (NYSE:PFE)'s PFE.N announcement that its COVID-19 vaccine was 95% effective and that the company would apply for emergency U.S. authorization within days. Pfizer's vaccine has a similar effectiveness as the candidate developed by Moderna Inc MRNA.O . like a seesaw, the fight between the growth of COVID and the excitement about the vaccine is really weighing on the market," said Hilary Kramer, chief investment officer for Kramer Capital Research in New York.

Australia's S&P/ASX 200 .AXJO lost 0.5% in early trading, while Hong Kong's Hang Seng index futures .HSI HSIc1 lost 0.02%. Japan's Nikkei 225 .N225 fell 0.4%.

New York City joined other large school districts in cities like Boston, Detroit, Las Vegas, Philadelphia that have recently canceled in-person learning due to rising coronavirus cases.

Forty-one U.S. states have reported record daily increases in COVID-19 cases in November, 20 have registered record daily deaths and 26 have reported new peaks in hospitalizations, according to a Reuters tally of public health data.

Despite upbeat vaccine developments, the prospect of roll-backs of reopenings and new lockdowns weighed on market participants. All 11 major sectors in the S&P 500 closed in negative territory, with energy shares .SPNY suffering the biggest loss.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Dow Jones Industrial Average .DJI fell 1.16%, the S&P 500 .SPX lost 1.16%, and the Nasdaq Composite .IXIC dropped 0.82%.

Richmond Federal Reserve President Thomas Barkin said allowing the Fed's emergency lending programs to sunset on Dec. 31 could pose risks to financial markets, especially as the pandemic is escalating. dollar moved off earlier lows following better-than-expected U.S. housing data, with the greenback still on pace for its fifth straight decline as the Pfizer news gave investors an appetite for some risk taking. dollar index =USD fell 0.043%, with the euro EUR= down 0.05% to $1.1855.

U.S. Treasury yields reversed early declines on optimism about a potential vaccine and after a weak 20-year bond auction diminished the appeal of the safe-haven debt. Benchmark 10-year notes US10YT=RR last fell 1/32 in price to yield 0.875%, from 0.872% late on Tuesday. prices advanced as the vaccine news buoyed investor appetite, along with hopes OPEC and its allies will delay a planned increase in oil output. crude CLc1 settled up 0.94% at $41.82 per barrel and Brent LCOc1 was at $44.34, up 1.35% on the day.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.